Table 2.

Cytotoxic Evaluation (GI₅₀, M) of Compounds 1 and 2 against Selected Tumor Cell Lines.

cell line	GI50 of 1 (M)	GI50 of 2 (M)
	Leukemia
CCRF-CEM	9.45 × 10−5	8.53 × 10−7
HL-60 (TB)		4.97 × 10−7
MOLT-4	>1.00 × 10−4	4.78× 10−6
	Non-Small Cell Lung Cancer
NCI-H460	4.12 × 10−5	9.59 × 10−7
NCI-H525	>1.00 × 10−4	7.80 × 10−6
NCI-H23	>1.00 × 10−4	9.40 × 10−6
	Colon Cancer
HCC-2998	>1.00 × 10−4	9.65 × 10−7
HCT-116	>1.00 × 10−4	2.84 × 10−7
	Melanoma
LOX IMVI	6.56 × 10−5	9.09 × 10−8
M14	>1.00 × 10−4	4.32× 10−6
	Ovarian Cancer
OVCAR-8	>1.00 × 10−4	5.79 × 10−7
	Renal Cancer
786-0	>1.00 × 10−4	8.17 × 10−7
SN12C	>1.00 × 10−4	3.31 × 10−6